GENELUX CORP (GNLX) is a publicly traded company in the Unknown sector. Across all available filings, 17 corporate insiders have executed 176 transactions totaling $16.3M, demonstrating a bearish sentiment with -$16.3M in net insider flow. The most recent transaction on Jan 2, 2026 involved a transaction of 275,000 shares valued at $0.
No significant insider buying has been recorded for GNLX in the recent period.
No significant insider selling has been recorded for GNLX in the recent period.
Based on recent SEC filings, insider sentiment for GNLX is bearish with an Insider Alignment Score of 0/100 and a net flow of -$16.3M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at GENELUX CORP (GNLX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 17 insiders are actively trading GNLX stock, having executed 176 transactions in the past 90 days. The most active insider is Aladar Szalay (Executive), who has made 61 transactions totaling $11.8M.
Get notified when executives and directors at GNLX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | Litten Jason | Chief Medical Officer | Award | 275,000 | $N/A | $0 | |
| Dec 5, 2025 | Smalling Ralph | Executive | Sale | 165 | $4.69 | $774 | |
| Dec 1, 2025 | Thomas John | Executive | Sale | 10,000 | $5.00 | $50.0K | |
| Nov 17, 2025 | Smalling Ralph | Executive | Sale | 343 | $5.37 | $1.8K | |
| Nov 17, 2025 | Cappello Joseph | Executive | Sale | 973 | $5.37 | $5.2K | |
| Nov 17, 2025 | Yu Yong | Executive | Sale | 973 | $5.37 | $5.2K | |
| Nov 17, 2025 | Zindrick Thomas | Executive | Sale | 4,509 | $5.37 | $24.2K | |
| Sep 3, 2025 | Smalling Ralph | Executive | Sale | 580 | $3.36 | $1.9K | |
| Sep 1, 2025 | Smalling Ralph | Executive | Award | 10,000 | $N/A | $0 | |
| Aug 27, 2025 | L. Tyree James | Executive | Award | 22,283 | $N/A | $0 | |
| Aug 27, 2025 | W. Smither John | Executive | Award | 22,283 | $N/A | $0 | |
| Aug 27, 2025 | Cappello Joseph | Executive | Award | 107,500 | $N/A | $0 | |
| Aug 27, 2025 | Smalling Ralph | Executive | Award | 26,230 | $N/A | $0 | |
| Aug 27, 2025 | Yu Yong | Executive | Award | 101,480 | $N/A | $0 | |
| Aug 27, 2025 | Mirabelli Mary | Executive | Award | 22,283 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 110 | $16.3M | 98.5% |
Exercise(M) | 6 | $252.0K | 1.5% |
Purchase(P) | 10 | $1.3K | 0.0% |
Award(A) | 44 | $0 | 0.0% |
Conversion(C) | 6 | $0 | 0.0% |
Insider selling pressure at GENELUX CORP has increased, with 17 insiders executing 176 transactions across all time. Total sales of $16.3M significantly outpace purchases of $1.3K, resulting in a net outflow of $16.3M. This selling activity appears largely discretionary, which may warrant closer attention from investors.